Literature DB >> 25410301

Microscopic and ultrastructural modifications of postmenopausal atrophic vaginal mucosa after fractional carbon dioxide laser treatment.

Nicola Zerbinati1, Maurizio Serati, Massimo Origoni, Massimo Candiani, Tommaso Iannitti, Stefano Salvatore, Francesco Marotta, Alberto Calligaro.   

Abstract

Vaginal atrophy occurring during menopause is closely related to the dramatic decrease in ovarian estrogens due to the loss of follicular activity. Particularly, significant changes occur in the structure of the vaginal mucosa, with consequent impairment of many physiological functions. In this study, carried out on bioptic vaginal mucosa samples from postmenopausal, nonestrogenized women, we present microscopic and ultrastructural modifications of vaginal mucosa following fractional carbon dioxide (CO2) laser treatment. We observed the restoration of the vaginal thick squamous stratified epithelium with a significant storage of glycogen in the epithelial cells and a high degree of glycogen-rich shedding cells at the epithelial surface. Moreover, in the connective tissue constituting the lamina propria, active fibroblasts synthesized new components of the extracellular matrix including collagen and ground substance (extrafibrillar matrix) molecules. Differently from atrophic mucosa, newly-formed papillae of connective tissue indented in the epithelium and typical blood capillaries penetrating inside the papillae, were also observed. Our morphological findings support the effectiveness of fractional CO2 laser application for the restoration of vaginal mucosa structure and related physiological trophism. These findings clearly coupled with striking clinical relief from symptoms suffered by the patients before treatment.

Entities:  

Mesh:

Year:  2014        PMID: 25410301     DOI: 10.1007/s10103-014-1677-2

Source DB:  PubMed          Journal:  Lasers Med Sci        ISSN: 0268-8921            Impact factor:   3.161


  19 in total

1.  Long-term effects of the menopause and sex hormones on skin thickness.

Authors:  M Brincat; C J Moniz; J W Studd; A Darby; A Magos; G Emburey; E Versi
Journal:  Br J Obstet Gynaecol       Date:  1985-03

2.  The molecular interactions of heat shock protein 47 (Hsp47) and their implications for collagen biosynthesis.

Authors:  T R Dafforn; M Della; A D Miller
Journal:  J Biol Chem       Date:  2001-10-09       Impact factor: 5.157

3.  Hsp47 as a collagen-specific molecular chaperone.

Authors:  Yoshihito Ishida; Kazuhiro Nagata
Journal:  Methods Enzymol       Date:  2011       Impact factor: 1.600

Review 4.  Morphology and physiological changes of genital skin and mucosa.

Authors:  Miranda A Farage; Howard I Maibach
Journal:  Curr Probl Dermatol       Date:  2011-02-10

5.  In vivo histological evaluation of a novel ablative fractional resurfacing device.

Authors:  Basil M Hantash; Vikramaditya P Bedi; Bhumika Kapadia; Zakia Rahman; Kerrie Jiang; Heather Tanner; Kin Foong Chan; Christopher B Zachary
Journal:  Lasers Surg Med       Date:  2007-02       Impact factor: 4.025

6.  Fractional CO2 laser: a novel therapeutic device upon photobiomodulation of tissue remodeling and cytokine pathway of tissue repair.

Authors:  F Prignano; P Campolmi; P Bonan; F Ricceri; G Cannarozzo; M Troiano; T Lotti
Journal:  Dermatol Ther       Date:  2009-11       Impact factor: 2.851

Review 7.  Review of fractional photothermolysis: treatment indications and efficacy.

Authors:  Emily P Tierney; David J Kouba; C William Hanke
Journal:  Dermatol Surg       Date:  2009-07-20       Impact factor: 3.398

Review 8.  Vulvovaginal atrophy.

Authors:  Maire B Mac Bride; Deborah J Rhodes; Lynne T Shuster
Journal:  Mayo Clin Proc       Date:  2010-01       Impact factor: 7.616

9.  Connective tissue remodeling induced by carbon dioxide laser resurfacing of photodamaged human skin.

Authors:  Jeffrey S Orringer; Sewon Kang; Timothy M Johnson; Darius J Karimipour; Ted Hamilton; Craig Hammerberg; John J Voorhees; Gary J Fisher
Journal:  Arch Dermatol       Date:  2004-11

10.  Cell biology: Collagen secretion explained.

Authors:  David J Stephens
Journal:  Nature       Date:  2012-02-22       Impact factor: 49.962

View more
  33 in total

1.  Microablative fractional CO2 laser for the genitourinary syndrome of menopause: power of 30 or 40 W?

Authors:  Eleni Pitsouni; Themos Grigoriadis; Matthew Falagas; Angeliki Tsiveleka; Stefano Salvatore; Stavros Athanasiou
Journal:  Lasers Med Sci       Date:  2017-08-02       Impact factor: 3.161

2.  Computer simulations of thermal tissue remodeling during transvaginal and transurethral laser treatment of female stress urinary incontinence.

Authors:  Luke A Hardy; Chun-Hung Chang; Erinn M Myers; Michael J Kennelly; Nathaniel M Fried
Journal:  Lasers Surg Med       Date:  2016-02-22       Impact factor: 4.025

3.  Optical clearing of vaginal tissues, ex vivo, for minimally invasive laser treatment of female stress urinary incontinence.

Authors:  Chun-Hung Chang; Erinn M Myers; Michael J Kennelly; Nathaniel M Fried
Journal:  J Biomed Opt       Date:  2017-01-01       Impact factor: 3.170

Review 4.  Laser therapy as a treatment modality for genitourinary syndrome of menopause: a critical appraisal of evidence.

Authors:  Angamuthu Arunkalaivanan; Hervinder Kaur; Oseka Onuma
Journal:  Int Urogynecol J       Date:  2017-02-02       Impact factor: 2.894

Review 5.  Laser Therapy for Genitourinary Syndrome of Menopause.

Authors:  Andrew Rabley; Tina O'Shea; Russell Terry; Sharon Byun; M Louis Moy
Journal:  Curr Urol Rep       Date:  2018-08-17       Impact factor: 3.092

6.  Carbon dioxide (CO2) laser ablation of symptomatic vaginal endometriosis: a pilot study.

Authors:  Laura Buggio; Ermelinda Monti; Carlo Liverani; Maria Pina Frattaruolo; Dhouha Dridi; Edgardo Somigliana
Journal:  Lasers Med Sci       Date:  2020-10-16       Impact factor: 3.161

7.  An international Urogynecological association (IUGA)/international continence society (ICS) joint report on the terminology for the assessment of sexual health of women with pelvic floor dysfunction.

Authors:  Rebecca G Rogers; Rachel N Pauls; Ranee Thakar; Melanie Morin; Annette Kuhn; Eckhard Petri; Brigitte Fatton; Kristene Whitmore; Sheryl A Kingsberg; Joseph Lee
Journal:  Int Urogynecol J       Date:  2018-03-26       Impact factor: 2.894

8.  Fractional CO2 laser for genitourinary syndrome of menopause in breast cancer survivors: clinical, immunological, and microbiological aspects.

Authors:  Angelamaria Becorpi; Giuseppina Campisciano; Nunzia Zanotta; Zelinda Tredici; Secondo Guaschino; Felice Petraglia; Annalisa Pieralli; Giovanni Sisti; Francesco De Seta; Manola Comar
Journal:  Lasers Med Sci       Date:  2018-03-01       Impact factor: 3.161

Review 9.  Exogenous reproductive hormone use in breast cancer survivors and previvors.

Authors:  Ines Vaz-Luis; Ann H Partridge
Journal:  Nat Rev Clin Oncol       Date:  2018-01-23       Impact factor: 66.675

Review 10.  Light and energy based therapeutics for genitourinary syndrome of menopause: Consensus and controversies.

Authors:  Yona Tadir; Adrian Gaspar; Ahinoam Lev-Sagie; Macrene Alexiades; Red Alinsod; Alex Bader; Alberto Calligaro; Jorge A Elias; Marco Gambaciani; Jorge E Gaviria; Cheryl B Iglesia; Ksenija Selih-Martinec; Patricia L Mwesigwa; Urska B Ogrinc; Stefano Salvatore; Paolo Scollo; Nicola Zerbinati; John Stuart Nelson
Journal:  Lasers Surg Med       Date:  2017-02-21       Impact factor: 4.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.